BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8080860)

  • 1. Renal cell carcinoma.
    Savage PD
    Curr Opin Oncol; 1994 May; 6(3):301-7. PubMed ID: 8080860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of molecular markers in the staging of renal cell carcinoma.
    Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
    BJU Int; 2007 May; 99(5 Pt B):1208-11. PubMed ID: 17441912
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal cell carcinoma: current status and emerging therapies.
    Nelson EC; Evans CP; Lara PN
    Cancer Treat Rev; 2007 May; 33(3):299-313. PubMed ID: 17329029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell carcinoma.
    Savage PD
    Curr Opin Oncol; 1993 May; 5(3):538-45. PubMed ID: 8494914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal cell carcinoma.
    Long GD
    Curr Opin Oncol; 1997 May; 9(3):301-6. PubMed ID: 9229154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case 36-2018: A 29-Year-Old Man with an Incidentally Discovered Renal Mass.
    Dahl DM; Simeone JF; Iliopoulos O; Saylor PJ; Wu CL
    N Engl J Med; 2018 Nov; 379(21):2064-2072. PubMed ID: 30462933
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytogenetic studies in renal cell carcinoma patients receiving low-dose recombinant interleukin-2-based immunotherapy.
    Duensing S; van den Berg-de Ruiter E; Störkel S; Kirchner H; Hänninen EL; Buer J; Poliwoda H; Atzpodien J
    Tumour Biol; 1996; 17(1):27-33. PubMed ID: 7501970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling of renal cell carcinoma and clinical implications.
    Rogers CG; Tan MH; Teh BT
    Urology; 2005 Feb; 65(2):231-7. PubMed ID: 15708028
    [No Abstract]   [Full Text] [Related]  

  • 9. Sarcomatoid renal cell carcinoma: Biology and treatment advances.
    Mouallem NE; Smith SC; Paul AK
    Urol Oncol; 2018 Jun; 36(6):265-271. PubMed ID: 29306556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney cancer in 2014: Key advances promise progress for kidney cancer patients.
    Ito T; Kutikov A
    Nat Rev Urol; 2015 Feb; 12(2):69-70. PubMed ID: 25600094
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal cell carcinoma.
    Savage PD
    Curr Opin Oncol; 1995 May; 7(3):275-80. PubMed ID: 7654830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolving role of cytoreductive surgery for metastatic renal cell carcinoma.
    Chaudhary UB; Hull GW
    Oncology (Williston Park); 2003 May; 17(5):701-5; discussion 705-6, 711-2. PubMed ID: 12800795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary Renal Cell Carcinoma Syndromes: Clinical, Pathologic, and Genetic Features.
    Adeniran AJ; Shuch B; Humphrey PA
    Am J Surg Pathol; 2015 Dec; 39(12):e1-e18. PubMed ID: 26559379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the biology and management of renal cell carcinoma.
    Dutcher JP
    J Investig Med; 2019 Jan; 67(1):1-10. PubMed ID: 30455223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal cell carcinoma molecular biology. Prognostic and therapeutic usefulness].
    Zudaire Bergera JJ; Rincón Mayans A; Rioja Zuazu J; Barba Abad J; Romero Vargas L; Algarra Navarro R; Tienza Fernández A; Robles García JE; Rosell Costa D; Berián Polo JM; Pascual Piédrola JI
    Arch Esp Urol; 2013; 66(1):23-32. PubMed ID: 23406797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal cell carcinoma.
    Mulders PF
    World J Urol; 2008 Apr; 26(2):113. PubMed ID: 18389254
    [No Abstract]   [Full Text] [Related]  

  • 17. Complexity of the genomic landscape of renal cell carcinoma: Implications for targeted therapy and precision immuno-oncology.
    Sanfrancesco JM; Cheng L
    Crit Rev Oncol Hematol; 2017 Nov; 119():23-28. PubMed ID: 29065981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Connexin32 as a tumor suppressor gene in renal cell carcinoma].
    Fujimoto E; Yano T; Ueno K
    Nihon Yakurigaku Zasshi; 2007 Feb; 129(2):105-9. PubMed ID: 17299236
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy for metastatic renal cell carcinoma: a review.
    Debruyne FM; de Mulder PH
    Prog Clin Biol Res; 1989; 303():621-7. PubMed ID: 2675016
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunotherapy of renal cell carcinoma.
    Gouttefangeas C; Stenzl A; Stevanović S; Rammensee HG
    Cancer Immunol Immunother; 2007 Jan; 56(1):117-28. PubMed ID: 16676181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.